Correlation Between Monthly Rebalance and Biotechnology Ultrasector
Can any of the company-specific risk be diversified away by investing in both Monthly Rebalance and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monthly Rebalance and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monthly Rebalance Nasdaq 100 and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Monthly Rebalance and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monthly Rebalance with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monthly Rebalance and Biotechnology Ultrasector.
Diversification Opportunities for Monthly Rebalance and Biotechnology Ultrasector
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monthly and Biotechnology is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Monthly Rebalance Nasdaq 100 and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Monthly Rebalance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monthly Rebalance Nasdaq 100 are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Monthly Rebalance i.e., Monthly Rebalance and Biotechnology Ultrasector go up and down completely randomly.
Pair Corralation between Monthly Rebalance and Biotechnology Ultrasector
Assuming the 90 days horizon Monthly Rebalance Nasdaq 100 is expected to generate 0.67 times more return on investment than Biotechnology Ultrasector. However, Monthly Rebalance Nasdaq 100 is 1.5 times less risky than Biotechnology Ultrasector. It trades about 0.33 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about 0.07 per unit of risk. If you would invest 42,568 in Monthly Rebalance Nasdaq 100 on April 27, 2025 and sell it today you would earn a total of 16,957 from holding Monthly Rebalance Nasdaq 100 or generate 39.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monthly Rebalance Nasdaq 100 vs. Biotechnology Ultrasector Prof
Performance |
| Timeline |
| Monthly Rebalance |
| Biotechnology Ultrasector |
Monthly Rebalance and Biotechnology Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monthly Rebalance and Biotechnology Ultrasector
The main advantage of trading using opposite Monthly Rebalance and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monthly Rebalance position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.| Monthly Rebalance vs. Great West Loomis Sayles | Monthly Rebalance vs. Palm Valley Capital | Monthly Rebalance vs. Hennessy Nerstone Mid | Monthly Rebalance vs. Goldman Sachs Small |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |